Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?

Springer, Journal of Neuroimmune Pharmacology, 2(16), p. 213-218, 2021

Journal article published in 2021 by Adriano José Maia Chaves Filho, Franciane Gonçalves, Melina Mottin

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by